Navigation Links
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
Date:11/19/2013

FRANKLIN LAKES, N.J., Nov. 19, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that the BD AccelerateSM program now offers a solution for the biopharmaceutical injectable drug market with the BD Neopak™ Glass Prefillable Syringe system. This make-to-stock program is designed to facilitate expedited delivery, within two weeks, of fully-validated BD syringe systems and associated quality systems documentation to pharmaceutical customers.

Launched in 2011, the program was designed to offer pharmaceutical customers faster access to fully-validated syringe systems that are optimized for biologics, vaccines and other parenteral medicines.  Based on BD's high-speed manufacturing capabilities, the BD AccelerateSM program allows the company to produce and store large quantities of fully-validated syringe components. This program represents a significant reduction in lead time versus traditional processes and provides customers with the advantage to initiate testing earlier in the drug development process.

"By offering faster access to a syringe system that is specifically engineered for the delivery of biopharmaceutical drugs, BD is positioned to provide an important advantage to companies developing these products to address a wide range of unmet healthcare needs," said Eric Borin, Vice President and General Manager – Americas, BD Medical – Pharmaceutical Systems. "The availability of the BD Neopak™ Glass Prefillable Syringe system through the BD AccelerateSM program demonstrates BD's understanding of its pharmaceutical partners' current challenges when bringing drugs to market for patients."

Building on more than 100 years of industry expertise, BD selected products suited to specific market needs with attributes to reduce regulatory and drug compatibility risks intended to enable pharmaceutical companies to expedite drug products through the development stages. The current syringe systems offered through the program include BD Neopak™ Glass Prefillable Syringes, BD Hypak™ Glass Prefillable Syringes and BD Hypak™ Glass Prefillable Syringes for Biotech.  As of January 2013, more than 40 BD pharmaceutical partners have participated in the BD AccelerateSM program.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Hydrocodone Restrictions Lead to Illegal Drug Use? Rapid Detox the Solution?
2. Kareo Expands Leadership Team to Support Rapid Growth
3. First rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies now available
4. Brazilian, Russian, Indian and Chinese Markets For Electrophysiology Mapping and Ablation Devices Will See Rapid Growth Through 2022
5. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
6. EQUOTE Allows Companies to Rapidly Tackle Business Loan Requirements
7. BD Supports the FDAs Proposal to Reclassify Rapid Influenza Tests
8. Community Pharmacies Are Effective Locations for Rapid HIV Testing
9. Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth
10. UnderPenetrated Latin American Varicose Vein Treatment Device Market Will Grow Rapidly Through 2021
11. Approval Of Boston Scientifics Watchman Device Will Support Rapid Growth In The Global Heart Defect Closure Device Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... December 2, 2016 bioLytical Laboratories, ein Weltführer bei ... den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical ...
(Date:12/2/2016)... Orthopedic Implants (Including Spinal Implants, Reconstructive Joint Implants, ... Significant Market Share Owing to a Large Global Baby Boomer ... ... According to a new report by Persistence Market Research titled ... Type Segment Projected to Witness a Significantly High CAGR Through ...
(Date:12/2/2016)... , December 2, 2016 On ... trading session in red, while the Dow Jones Industrial Average ... the close of US markets, which prompted Stock-callers this morning ... NuVasive Inc. (NASDAQ: NUVA ), Smith & Nephew ... NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... The ... Waikiki Beach Resort and Spa in Honolulu, offering local frontline clinicians the opportunity ... management. , The demand for supplemental training related to pain management has ...
(Date:12/2/2016)... ... 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique ... other wearable health technology on the market can deliver all that rejiva can. , ... insights about their health than the usual heart rate and steps taken”, adds Evens ...
(Date:12/2/2016)... ... 02, 2016 , ... Clarify Health Solutions, Inc., the leading ... in an initial round of funding. The round was led by experienced investors ... receive far better care through the application of the best technologies from other ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health radio ...
(Date:11/30/2016)... ... November 30, 2016 , ... Northridge ... in-house dental plan for all patients. Understanding that budget can play a part ... a number of perks, including discounts on many valuable dental treatments. Options for ...
Breaking Medicine News(10 mins):